AT-02

· Attralus, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AT-02, covering 2025-08-24 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AT-02 in Subjects With Systemic Amyloidosis. [Phase 2]